Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Hologic Inc HOLX

Healthcare Medical Devices
Hologic, Inc. is a medical technology company focused on improving women's health and well-being through early detection and treatment. It is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products... see more

Recent & Breaking News (NDAQ:HOLX)

Hologic Announces Multi-Year, Multi-Pronged Commitment to Tackling Breast Cancer Screening Disparities for Black Women in Partnership with the Black Women's Health Imperative and RAD-AID

Business Wire October 1, 2020

Hologic Granted FDA Emergency Use Authorization for Asymptomatic COVID-19 Testing with Panther Fusion SARS-CoV-2 Assay

Business Wire September 28, 2020

Hologic Announces Pricing of Offering of $950 Million of 3.250% Senior Notes Due 2029

Business Wire September 14, 2020

Hologic Announces Offering of $950 Million of Senior Notes Due 2029

Business Wire September 14, 2020

Hologic to Webcast Presentations at Upcoming Investor Conferences

Business Wire September 4, 2020

Hologic to Acquire Acessa Health, Innovator in Minimally Invasive Solutions for Treatment of Fibroids

Business Wire August 25, 2020

Hologic Launches Validated Pooling Protocol for COVID-19 Testing

Business Wire August 11, 2020

Hologic Announces 'Back to Screening' Campaign Encouraging Women to Prioritize Mammograms Delayed due to COVID-19 Pandemic

Business Wire August 3, 2020

New Cervical Cancer Screening Guidelines from the American Cancer Society Risk Reversing Decades of Progress Made Against Cervical Cancer

Business Wire July 31, 2020

Hologic Announces Financial Results for Third Quarter of Fiscal 2020

Business Wire July 29, 2020

Hologic Launches its First Cart-Based Ultrasound System, SuperSonic(TM) MACH 40

Business Wire July 8, 2020

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2020 on Wednesday, July 29, 2020

Business Wire July 2, 2020

Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences

Business Wire June 1, 2020

Hologic Granted FDA Emergency Use Authorization for Its Second Molecular Test for COVID-19

Business Wire May 15, 2020

Hologic to Webcast Presentations at Upcoming Investor Conferences

Business Wire May 6, 2020

Hologic Announces Financial Results for Second Quarter of Fiscal 2020

Business Wire April 29, 2020

Hologic to Introduce Its Second High-Throughput Molecular Assay for the Novel Coronavirus (SARS-CoV-2)

Business Wire April 29, 2020

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2020 on Wednesday, April 29, 2020

Business Wire April 7, 2020

Hologic Announces Preliminary Revenue Results for Second Quarter of Fiscal 2020, Withdraws 2020 Financial Guidance due to COVID-19 Pandemic

Business Wire April 7, 2020

Hologic's Molecular Test for the Novel Coronavirus, SARS-CoV-2, Receives FDA Emergency Use Authorization

Business Wire March 16, 2020